0HRS Stock Chart & Stats
$93.06
-$0.35(-0.33%)
At close: 4:00 PM EDT
$93.06
-$0.35(-0.33%)
Day’s Range― - ―
52-Week Range$69.18 - $112.00
Previous CloseN/A
Volume930.00
Average Volume (3M)5.32K
Market Cap
$110.58B
Enterprise Value$195.69B
Total Cash (Recent Filing)$13.96B
Total Debt (Recent Filing)$76.31B
Price to Earnings (P/E)22.6
Beta0.49
Next Earnings
Nov 04, 2026EPS Estimate
1.64Next Dividend Ex-DateN/A
Dividend Yield3.09%
Share Statistics
EPS (TTM)3.83
Shares Outstanding1,278,970,300
10 Day Avg. Volume5,419
30 Day Avg. Volume5,319
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap1.77
Enterprise Value/Revenue0.47
Enterprise Value/Gross Profit3.33
Enterprise Value/Ebitda14.59
Forecast
1Y Price Target
$114.37Price Target Upside22.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
EPS Forecast (FY)8.02
Revenue Forecast (FY)$416.52B
Bulls Say, Bears Say
Bulls Say
Cash Generation And DeleveragingStrong and improving cash generation gives CVS greater capacity to fund operations, reduce debt, and invest in healthcare capabilities. The concurrent deleveraging trend improves financial flexibility and provides a more durable foundation for managing reimbursement or utilization pressure.
Health Services GrowthCaremark and related Health Services operations are showing meaningful revenue and profit growth, supported by purchasing economics, pharmacy mix, and specialty performance. Continued scale in these services can strengthen CVS’s integrated platform and support earnings resilience.
Specialty Pharmacy AdvantageConsistently higher adherence indicates a meaningful operational and technology advantage in specialty pharmacy, where outcomes and therapy persistence are important. This capability can support client retention, improve patient results, and reinforce CVS’s position in a structurally growing care category.
Bears Say
Compressed ProfitabilityVery thin and reduced margins leave CVS with limited earnings cushion when medical costs, reimbursement, or operating expenses increase. Although revenue remains large, weaker profitability and depressed returns indicate that scale is not currently translating into consistently strong economic efficiency.
340B Program PressureOngoing 340B pressure can weigh on pharmacy economics beyond a single quarter because the program environment and manufacturer restrictions affect how related services are priced and reimbursed. The unresolved headwind could limit margin recovery and complicate forward earnings planning.
Caremark Membership DeclineLower Caremark membership could reduce the scale supporting CVS’s purchasing, claims-processing, and benefit-management economics. Even disciplined client selection may create a period of revenue and volume pressure, while product exits and weaker retention make future growth less predictable.
CVS Health News
0HRS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest share price was $69.18 and its highest was $112.00 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $110.58B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Nov 04, 2026 which is in 31 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Aug 05, 2026. The company reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.854 by $0.726.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.09%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.64.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,278,970,300 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.58 in its last earnings report, beating expectations of $1.854. Following the earnings report the stock price went down -4.627%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in GB:0HRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$114.37 (22.90% Upside)
$114.37 (22.90% Upside)
Blogger Sentiment
Bullish
GB:0HRS Sentiment 76%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.17%
12-Months-Change
Fundamentals
Return on Equity
3.09%
Trailing 12-Months
Asset Growth
-1.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
0HRS Company Deck
0HRS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum across segments with material upside: double-digit growth in operating income, raised EPS guidance, improved cash flow outlook, specialty leadership, and early tangible AI-driven efficiencies. Offsetting these positives are notable industry-specific headwinds—most prominently near-term 340B pressures, anticipated Caremark membership declines in 2027, ongoing reimbursement and regulatory pressures, and some timing-related pull-forwards. Management emphasized disciplined execution, balance sheet improvement and a multi-year growth outlook (mid-teens EPS CAGR through 2028), while acknowledging and preparing for specific near-term headwinds.View all GB:0HRS earnings summaries0HRS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
0HRS Stock 12 Month Forecast
Average Price Target
$114.37
▲(22.90% Upside)